Vascarta has obtained the exclusive rights to a novel method of creating more effective cancer therapies with fewer side effects applying new and unique linker chemistry developed by the City College ...

Ginsenoside AD-2 Ameliorating Lipopolysaccharide-Induced Activation in HSC-T6 Cells and Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice via Regulation of VD-VDR Axis.